Wednesday, June 10, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 41 of 1,261
  1. US 12311029

    Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein

    Northwestern University Β· Granted May 27, 2025 Β· Expires May 22, 2045

    granted
  2. US 12310954

    Salivary gland regeneration

    The Regents of the University of California Β· Granted May 27, 2025 Β· Expires May 22, 2045

    granted
  3. US 12310996

    Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome

    The Board of Regents of the University of Texas System Β· Granted May 27, 2025 Β· Expires May 22, 2045

    granted
  4. US 12311017

    Identification of immunologically protective neo-epitopes for the treatment of cancers

    UNIVERSITY OF CONNECTICUT Β· Granted May 27, 2025 Β· Expires May 22, 2045

    granted
  5. US 12310943

    Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

    Amazentis SA Β· Granted May 27, 2025 Β· Expires May 22, 2045

    granted
  6. US 12310988

    BCMA chimeric antigen receptors and uses thereof

    The Board of Regents of the University of Texas System Β· Granted May 27, 2025 Β· Expires May 22, 2045

    granted
  7. US 12312589

    RNA-nanostructured double robots and methods of use thereof

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted May 27, 2025 Β· Expires May 22, 2045

    granted
  8. US 12310968

    Chiral diaryl macrocycles and uses thereof

    TURNING POINT THERAPEUTICS, INC. Β· Granted May 27, 2025 Β· Expires May 22, 2045

    granted
  9. US 12311054

    Compositions and methods of using propylene sulfide-based polymers for treatment of Chagas disease

    Northwestern University Β· Granted May 27, 2025 Β· Expires May 22, 2045

    granted
  10. US 12312334

    Quinoxaline compounds and uses thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted May 27, 2025 Β· Expires May 22, 2045

    granted
  11. WO 2025106633

    INHIBITEURS DE TYK2

    BIOGEN MA INC [US] Β· Granted May 22, 2025 Β· Expires May 17, 2045

    granted
  12. US 12304908

    Azabenzimidazoles and their use as AMPA receptor modulators

    Rapport Therapeutics, Inc. Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  13. US 12304940

    HLA class II-restricted t cell receptors against mutated RAS

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  14. US 12304964

    CD38 modulating antibody

    BLACK BELT THERAPEUTICS LIMITED Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  15. US 12304942

    Cell comprising a chimeric antigen receptor or a transgenic T-cell receptor and comprising a chimeric TNF receptor

    AUTOLUS LIMITED Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  16. US 12304930

    Prefusion-stabilized hMPV F proteins

    The Board of Regents of the University of Texas System Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  17. US 12304969

    Factor XI A2 domain-binding antibodies and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  18. US 12304901

    Selective ligands for tau aggregates

    Sentonix, Inc. Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  19. US 12304912

    Fused bicyclic RAF inhibitors and methods for use thereof

    Jazz Pharmaceuticals Ireland Limited Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  20. US 12303618

    Oxygen-generating cryogels

    Northwestern University Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  21. US 12304968

    T-cells expressing anti-LIV1 chimeric antigen receptor

    CRISPR THERAPEUTICS AG Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  22. US 12304900

    Islet cell manufacturing compositions and methods of use

    Vertex Pharmaceuticals Incorporated Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  23. US 12303481

    Levodopa dosing regimen

    AMNEAL PHARMACEUTICALS LLC Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted
  24. US 12304898

    Quinolyl-containing compound and pharmaceutical composition, and use thereof

    PrimeGene (Beijing) Co., Ltd. Β· Granted May 20, 2025 Β· Expires May 15, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.